Interleukin-12 Plus Interleukin-2 in Treating Patients With Advanced Solid Tumors

NCT00005604 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: recombinant interleukin-12
BIOLOGICAL: aldesleukin
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)